STAMFORD, Conn., Sept. 11, 2023 GeneDx a leader in delivering improved health outcomes through genomic and clinical insights, today announced the expansion and evolution of its executive.
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) Director Richard C. Pfenniger, Jr. purchased 5,000 shares of the business’s stock in a transaction dated Thursday, August 17th. The stock was bought at an average cost of $5.10 per share, for a total transaction of $25,500.00. Following the purchase, the director now owns 10,918 shares in […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) Director Richard C. Pfenniger, Jr. bought 5,000 shares of GeneDx stock in a transaction dated Thursday, August 17th. The shares were acquired at an average cost of $5.10 per share, for a total transaction of $25,500.00. Following the completion of the purchase, the director now directly owns […]
Operator: Good day, and thank you for standing by. Welcome to the GeneDx Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Be advised that today s conference is being recorded.
DocGo (NASDAQ:DCGO – Get Free Report) and GeneDx (NASDAQ:WGS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Profitability This table compares DocGo and GeneDx’s net margins, […]